- Home
- XERS vs HCKT Comparison
XERS vs HCKT Comparison
Compare XERS & HCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- HCKT
- Stock Information
- Founded
- XERS 2005
- HCKT 1991
- Country
- XERS United States
- HCKT United States
- Employees
- XERS N/A
- HCKT N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- HCKT Professional Services
- Sector
- XERS Health Care
- HCKT Consumer Discretionary
- Exchange
- XERS Nasdaq
- HCKT Nasdaq
- Market Cap
- XERS 752.7M
- HCKT 636.1M
- IPO Year
- XERS 2018
- HCKT 1998
- Fundamental
- Price
- XERS $5.49
- HCKT $23.17
- Analyst Decision
- XERS Strong Buy
- HCKT Strong Buy
- Analyst Count
- XERS 6
- HCKT 3
- Target Price
- XERS $6.25
- HCKT $31.33
- AVG Volume (30 Days)
- XERS 1.8M
- HCKT 204.0K
- Earning Date
- XERS 08-07-2025
- HCKT 08-05-2025
- Dividend Yield
- XERS N/A
- HCKT 2.06%
- EPS Growth
- XERS N/A
- HCKT N/A
- EPS
- XERS N/A
- HCKT 0.84
- Revenue
- XERS $222,551,000.00
- HCKT $307,532,000.00
- Revenue This Year
- XERS $35.31
- HCKT $6.06
- Revenue Next Year
- XERS $19.65
- HCKT $5.46
- P/E Ratio
- XERS N/A
- HCKT $27.68
- Revenue Growth
- XERS 29.88
- HCKT 3.49
- 52 Week Low
- XERS $2.10
- HCKT $21.44
- 52 Week High
- XERS $6.07
- HCKT $34.02
- Technical
- Relative Strength Index (RSI)
- XERS 62.75
- HCKT 38.65
- Support Level
- XERS $4.94
- HCKT $22.69
- Resistance Level
- XERS $5.22
- HCKT $23.65
- Average True Range (ATR)
- XERS 0.22
- HCKT 0.53
- MACD
- XERS -0.01
- HCKT -0.03
- Stochastic Oscillator
- XERS 86.44
- HCKT 20.85
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About HCKT Hackett Group Inc (The).
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.